Trial Profile
Rapamycin Study of the Effect on Muscular Strength and Immune response to the lessons of Myositis Inclusions: study RAPAMI
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 16 Jan 2019
Price :
$35
*
At a glance
- Drugs Sirolimus (Primary)
- Indications Inclusion body myositis
- Focus Therapeutic Use
- Acronyms RAPAMI
- 08 Jan 2019 Status changed from active, no longer recruiting to completed.
- 17 Jan 2017 Planned End Date changed from 1 Mar 2018 to 1 Apr 2018.
- 17 Jan 2017 Planned primary completion date changed from 1 Mar 2018 to 1 Apr 2018.